AI-powered health screening platform utilizing multimodal optical imaging and computational biology models to predict health status across multiple dimensions. Integrates genomic, RNA, cellular, and phenotypic data with large language models for non-invasive assessment of biomarkers, blood glucose, ...
Manufactured by
Feipu Intelligent Technology (Shanghai) Co., Ltd.
China
Feipu Intelligent Technology (Shanghai) Co., Ltd., founded in 2021 in Shanghai Free Trade Zone, is a biocomputing and predictive technology company pioneering non-invasive health screening and facial reconstruction from DNA. The core team comprises researchers from Yale, Columbia, Mount Sinai Medical School, Sanger Institute, and Chinese Academy of Sciences, specializing in computational genomics, complex trait prediction models, and AI-based facial phenotype health prediction.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Mediwhale Inc.
South Korea · 1 relevant product
Infervision
China · 1 relevant product
Beijing Tsingray Technology Co., Ltd.
China · 1 relevant product
50 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →10 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 68 closest product alternatives
Mediwhale Inc. · South Korea
Integrated AI platform for early detection and personalized risk assessment of cardiometabolic diseases through retinal imaging analysis. Designed for seamless integration into hospital and clinic information systems globally.
Infervision · China
AI-powered diagnostic platform utilizing deep learning and convolutional neural networks to assist clinicians in detecting and analyzing diseases across multiple organ systems including lungs, cardiovascular, breast, and skeletal structures. Integrates medical imaging analysis with clinical workflow support for disease screening, diagnosis, and treatment planning across oncology, infectious disease, and cardiovascular applications.
Beijing Tsingray Technology Co., Ltd. · China
An AI-powered clinical diagnostic system designed to improve screening efficiency and diagnostic accuracy in healthcare settings. The platform integrates health AI models trained on over 50 million hours of real-world data and 50,000 medical-grade clinical data points to support multi-disease diagnosis and clinical decision-making across various healthcare scenarios.
65 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products